The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and ...

the right inhaler for the right person. There are various problems in administering asthma and COPD treatment to patients. In asthma, for example, people don't necessarily perceive that they have ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW medical editor Dr. Brian McDonough has more.

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Medicare usually covers the cost of inhalers for people with ... important treatments for asthma and COPD. With Medicare, coverage for prescription drugs you take at home is available through ...

A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...

"This may inform prescribing of glucose-lowering medications among patients with T2D and active COPD," making SGLT2 ... witness in litigation against inhaler manufacturers outside the submitted ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...